Abstract
From many studies it is quite clear that the prognosis for lung cancer is best if it is detected in a presymptomatic stage. It is therefore natural to conceive that the overall mortality of lung cancer could be diminished through screening of high-risk groups with chest X-rays and/or sputum cytology and/or fiber optic bronchoscopy or by other innovative methods. Through early detection more and more patients could undergo resection and the overall survival-rate improve, and since the population at risk can be clearly defined (e.g. male smokers aged over 45 years), the possibility of screening for early diagnosis and more effective treatment is highly attractive.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Weiss W, Boucot KR, Seidman H (1982) The Philadelphia pulmonary neoplasm research project. Clin Chest Med 3: 243–256
Woolner LB, Fontana RS, Sanderson DR, et al. (1981) Mayo lung project. May Clin Proc 56: 544–547
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Spiro, S.G., Hansen, H.H. (1988). Early Detection: Screening. In: Hoogstraten, B., Addis, B.J., Hansen, H.H., Martini, N., Spiro, S.G. (eds) Lung Tumors. UICC Current Treatment of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82873-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-82873-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16920-8
Online ISBN: 978-3-642-82873-7
eBook Packages: Springer Book Archive